Literature DB >> 20183406

An adjudicated hermeneutic single-case efficacy design study of experiential therapy for panic/phobia.

Robert Elliott1, Rhea Partyka, Rebecca Alperin, Robert Dobrenski, John Wagner, Stanley B Messer, Jeanne C Watson, Louis G Castonguay.   

Abstract

This article illustrates the application of an adjudicated form of hermeneutic single-case efficacy design, a critical-reflective method for inferring change and therapeutic influence in single therapy cases. The client was a 61-year-old European-American male diagnosed with panic and bridge phobia. He was seen for 23 sessions of individual process-experiential/emotion-focused therapy. In this study, affirmative and skeptic teams of researchers developed opposing arguments regarding whether the client changed over therapy and whether therapy was responsible for these changes. Three judges representing different theoretical orientations then assessed data and arguments, rendering judgments in favor of the affirmative side. The authors discuss clinical implications and recommendations for future interpretive case study research.

Entities:  

Mesh:

Year:  2009        PMID: 20183406     DOI: 10.1080/10503300902905947

Source DB:  PubMed          Journal:  Psychother Res        ISSN: 1050-3307


  3 in total

1.  Lifespan Integration Therapy with Trauma-Exposed Children: a Hermeneutic Single Case Efficacy Study.

Authors:  Chris Rensch; Janelle Kwee; Larissa Rossen; Marvin McDonald
Journal:  J Child Adolesc Trauma       Date:  2021-05-29

2.  Studying the Efficacy of Psychodrama With the Hermeneutic Single Case Efficacy Design: Results From a Longitudinal Study.

Authors:  António-José Gonzalez; Paulo Martins; Margarida Pedroso de Lima
Journal:  Front Psychol       Date:  2018-09-10

3.  The Action of Verbal and Non-verbal Communication in the Therapeutic Alliance Construction: A Mixed Methods Approach to Assess the Initial Interactions With Depressed Patients.

Authors:  Luca Del Giacco; M Teresa Anguera; Silvia Salcuni
Journal:  Front Psychol       Date:  2020-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.